PD-L1 expression in ≥1% of tumor cells was associated with CDX2 negativity, right-sided cancer, dMMR, and a high infiltration of CD3+ and CD8+ intraepithelial and stromal TILs (Table 2). Here, CDX2 is linked to cancer.